Michael Halstead, EVP & GC at Intra-Cellular Therapies, holds 0.00 shares in Intra-Cellular Therapies (Ticker: ITCI), holds 15.36K shares in Warner Chilcott (Ticker: WCRX).

See the Hottest Stocks Based on Insider Trading >

Michael Halstead
Intra-Cellular Therapies (ITCI)
EVP & GC

Ranked #24,463 out of 98,501 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

+87.40%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

Michael Halstead does not currently own shares as a corporate insider.

A breakdown of Michael Halstead's holdings

See the Top Stocks by Insiders

Insider Roles

Intra-Cellular Therapies
(ITCI)

EVP & GC

Roles that Michael Halstead holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Intra-Cellular Therapies
(ITCI)

Rating:Informative Buy

Date:Nov 06, 2014 - Nov 06, 2015

Return:+229.90%

The most profitable trade made by Michael Halstead

See the Latest Stocks Traded by Insiders

Michael Halstead's Trading History

ITCI

Intra-Cellular Therapies

Mar 11, 2024

EVP & GC

Uninformative Sell

1.35M

$0.00

WCRX

Warner Chilcott

Jun 02, 2011

―

Uninformative Buy

―

List of latest transactions for each holding click on a transaction to see Michael Halstead's performance on stock

See All Insider Trading from Today

Michael Halstead insider profile FAQ

What is the percentage of profitable transactions made by Michael Halstead?

The percentage of profitable transactions made by Michael Halstead is 50%.

What is the average return per transaction made by Michael Halstead?

The average return per transaction made by Michael Halstead is 87.40%.

What stocks does Michael Halstead hold?

Michael Halstead holds: ITCI, WCRX stocks.

What was Michael Halstead’s latest transaction?

Michael Halstead latest transaction was an Uninformative Sell of $1.35M.

What was Michael Halstead's most profitable transaction?

Michael Halstead’s most profitable transaction was an Informative Buy of ITCI stock on November 6, 2014. The return on the trade was 229.90%.

What is Michael Halstead's role in Intra-Cellular Therapies?

Michael Halstead's role in Intra-Cellular Therapies is EVP & GC.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Michael Halstead Insider Profile

Michael Halstead Intra-Cellular Therapies (ITCI)EVP & GC